Third Dose of COVID-19 Vaccines May Boost Immunity in Patients with Hematologic Cancers
August 22nd 2022A third dose of mRNA COVID-19 vaccines may allow most immune compromised patients with hematologic cancers to achieve antibody response levels similar to those of healthy adults after a two-dose series.
Read More
Predicting Vaccine Effectiveness Based on Genetic Distance of SARS-CoV-2 Variants
June 30th 2022A computational framework for estimating vaccine effectiveness based on genetic differences of SARS-CoV-2 variants showed promising results in a new study that verified the model with clinical trial data.
Read More
CDC Director Endorses ACIP Recommendation for Moderna COVID-19 Vaccine for Children and Adolescents
June 26th 2022Rochelle P. Walensky, MD, MPH, signs off on the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices’ (ACIP) recommendation for individuals 6 through 17 years of age.
Read More